Greystone Associates Analyzes Technical, Economic and Usability Factors Fueling the Proliferation of Innovative Syringes and Injectors

Greystone Associates Business and Technology Factors Fueling the Trend to Combination Devices

Greystone Associates Finds Cost, Compliance Factors Influencing Dosing and Device Strategies

Applied Data Research Study Finds Therapy-Specific Devices and Patient-Centered Design Focus Creating New Opportunities

Greystone Associates Analyzes the Impact of Protein and Peptide Drugs on Chronic Disease Segments